nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—NR3C2—collecting duct of renal tubule—nephrolithiasis	0.128	0.38	CbGeAlD
Eplerenone—Serum potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0836	0.126	CcSEcCtD
Eplerenone—NR3C2—nephron—nephrolithiasis	0.0568	0.169	CbGeAlD
Eplerenone—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0402	0.0605	CcSEcCtD
Eplerenone—CYP11B2—renal system—nephrolithiasis	0.0252	0.0753	CbGeAlD
Eplerenone—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0347	CcSEcCtD
Eplerenone—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0297	CcSEcCtD
Eplerenone—CYP3A4—urine—nephrolithiasis	0.0185	0.0551	CbGeAlD
Eplerenone—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0265	CcSEcCtD
Eplerenone—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0247	CcSEcCtD
Eplerenone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.016	0.0477	CbGeAlD
Eplerenone—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0222	CcSEcCtD
Eplerenone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.0137	0.0408	CbGeAlD
Eplerenone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0202	CcSEcCtD
Eplerenone—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0197	CcSEcCtD
Eplerenone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0193	CcSEcCtD
Eplerenone—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0186	CcSEcCtD
Eplerenone—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0185	CcSEcCtD
Eplerenone—NR3C2—nephron tubule—nephrolithiasis	0.0123	0.0365	CbGeAlD
Eplerenone—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0183	CcSEcCtD
Eplerenone—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0179	CcSEcCtD
Eplerenone—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0172	CcSEcCtD
Eplerenone—NR3C2—renal system—nephrolithiasis	0.0111	0.0332	CbGeAlD
Eplerenone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0163	CcSEcCtD
Eplerenone—NR3C2—kidney—nephrolithiasis	0.0108	0.0321	CbGeAlD
Eplerenone—NR3C2—cortex of kidney—nephrolithiasis	0.0105	0.0313	CbGeAlD
Eplerenone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0152	CcSEcCtD
Eplerenone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0143	CcSEcCtD
Eplerenone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00929	0.014	CcSEcCtD
Eplerenone—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0139	CcSEcCtD
Eplerenone—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0133	CcSEcCtD
Eplerenone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00874	0.0131	CcSEcCtD
Eplerenone—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00825	0.0124	CcSEcCtD
Eplerenone—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00804	0.0121	CcSEcCtD
Eplerenone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00801	0.0121	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00793	0.0119	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00777	0.0117	CcSEcCtD
Eplerenone—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0112	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00707	0.0106	CcSEcCtD
Eplerenone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00687	0.0103	CcSEcCtD
Eplerenone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00683	0.0103	CcSEcCtD
Eplerenone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00669	0.0101	CcSEcCtD
Eplerenone—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00667	0.01	CcSEcCtD
Eplerenone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00665	0.01	CcSEcCtD
Eplerenone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00665	0.01	CcSEcCtD
Eplerenone—CYP3A5—nephron tubule—nephrolithiasis	0.00663	0.0198	CbGeAlD
Eplerenone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00993	CcSEcCtD
Eplerenone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00974	CcSEcCtD
Eplerenone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00606	0.00912	CcSEcCtD
Eplerenone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00605	0.0091	CcSEcCtD
Eplerenone—CYP3A5—renal system—nephrolithiasis	0.00602	0.018	CbGeAlD
Eplerenone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.006	0.00903	CcSEcCtD
Eplerenone—CYP3A5—kidney—nephrolithiasis	0.00582	0.0174	CbGeAlD
Eplerenone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00568	0.00855	CcSEcCtD
Eplerenone—CYP3A5—cortex of kidney—nephrolithiasis	0.00567	0.0169	CbGeAlD
Eplerenone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00851	CcSEcCtD
Eplerenone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00786	CcSEcCtD
Eplerenone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00772	CcSEcCtD
Eplerenone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00767	CcSEcCtD
Eplerenone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00741	CcSEcCtD
Eplerenone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00738	CcSEcCtD
Eplerenone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00729	CcSEcCtD
Eplerenone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0072	CcSEcCtD
Eplerenone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00716	CcSEcCtD
Eplerenone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00701	CcSEcCtD
Eplerenone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00696	CcSEcCtD
Eplerenone—CYP3A4—renal system—nephrolithiasis	0.00452	0.0135	CbGeAlD
Eplerenone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00679	CcSEcCtD
Eplerenone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00679	CcSEcCtD
Eplerenone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00679	CcSEcCtD
Eplerenone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00671	CcSEcCtD
Eplerenone—CYP3A4—kidney—nephrolithiasis	0.00437	0.013	CbGeAlD
Eplerenone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00641	CcSEcCtD
Eplerenone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0063	CcSEcCtD
Eplerenone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00609	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00593	CcSEcCtD
Eplerenone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00589	CcSEcCtD
Eplerenone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00581	CcSEcCtD
Eplerenone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00573	CcSEcCtD
Eplerenone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00562	CcSEcCtD
Eplerenone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00557	CcSEcCtD
Eplerenone—Pain—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00557	CcSEcCtD
Eplerenone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00537	CcSEcCtD
Eplerenone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00533	CcSEcCtD
Eplerenone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00515	CcSEcCtD
Eplerenone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00515	CcSEcCtD
Eplerenone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00467	CcSEcCtD
Eplerenone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00461	CcSEcCtD
Eplerenone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00446	CcSEcCtD
Eplerenone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00431	CcSEcCtD
Eplerenone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00414	CcSEcCtD
Eplerenone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00411	CcSEcCtD
Eplerenone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00273	0.0041	CcSEcCtD
Eplerenone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00408	CcSEcCtD
Eplerenone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00387	CcSEcCtD
